DCM Shriram Fine Chemicals promoter Alok Bansidhar Shiram is set to acquire 2,69,06,206 equity shares, representing 30.94% of the company's shareholding, from Urvashi Tilakdhar. The transaction is scheduled for October 9, 2026.

The acquisition is structured as an off-market inter-se transfer among promoters and immediate relatives. It is executed as an inter-family gift out of love and affection, with no monetary consideration involved. The disclosure was submitted under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

The pre-transaction report confirms that Alok Bansidhar Shiram, already a promoter, will increase his individual holding significantly. The shares are being transferred from Mrs. Urvashi Tilakdhar, who currently holds the entire block. The acquirer is exempted from making an open offer under Regulation 10(1)(a)(i).

Impact on Promoter Group Holding

This transaction represents a consolidation of ownership within the promoter family rather than a change in external control. Following the transfer, Alok Bansidhar Shiram’s individual holding will rise from 10.28% to 41.22%, while Urvashi Tilakdhar’s holding will drop to zero. The aggregate promoter group holding remains unchanged at 50.11%.

Pre- and Post-Transaction Holdings

The following table outlines the significant holdings within the Persons Acting in Concert (PAC) framework before and after the proposed transaction:

What the Numbers Show

The data reveals a significant concentration of promoter wealth in a single individual following this transfer. Alok Bansidhar Shiram’s stake jumps by 30.94 percentage points, consolidating his position as the primary holder with 41.22% of the total voting capital. This follows an earlier internal reallocation where Bansuri Charitable Society acquired 3.42% from Akshay Foundation in September 2026. Both transactions highlight ongoing estate planning or charitable structuring within the promoter group, ensuring the overall promoter confidence and control level remains stable at 50.11% despite significant shifts in individual entity holdings.

DCM Shriram Fine Chemicals board ratified the payment of ₹3,02,080 to both BSE and NSE on September 21, 2026, settling penalties for non-compliance with SEBI’s Listing Obligations and Disclosure Requirements (LODR). The fines address a temporary gap in independent director representation during Q2FY27.

The company disclosed that the non-compliance stemmed from delays in identifying a suitable candidate for the position of Independent Director. This gap affected compliance with Regulation 17(1) of the SEBI (LODR) Regulations, 2015, for the quarter ended June 30, 2026.

Compliance Timeline

The board noted that the requirement under Regulation 17(1A) had been complied with on May 29, 2026. However, the violation of Regulation 17(1) persisted until the appointment of Mr. Nitin Atroley as Independent Director effective July 15, 2026.

Company Secretary Kokila Arora confirmed that the company was fully compliant with applicable provisions as of the date the exchange notices were received on August 25, 2026.

Board Directive

The board took the notices on record and approved the management’s decision to pay the fines to conclude the matter. It directed management to ensure strict adherence to all SEBI (LODR) regulations moving forward to prevent recurrence.